In Vitro Lung Model Market

The global in vitro lung model market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. Lung in vitro models are defined as cell models that represent a normal or diseased lung physiology. These cells when constructed in a monolayer on a petri plate are called 2D in vitro models. 3D models have a 3-dimensional architecture and use supports and scaffolds to maintain their structure. 3D models can be made in-house using consumables and are also available commercially as ready-to-use in vitro models.

Objectives of the Study

• To define, describe, and forecast the lung in vitro models by type, application, and region
• To provide detailed information about factors influencing market growth (drivers, opportunities, and challenges)
• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and details of the competitive landscape for market leaders
• To forecast the size of in vitro lung model market segments with respect to the four main regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
• To profile key players and comprehensively analyze their core competencies in terms of key market developments, product portfolios, and financials
• To track and analyze competitive developments such as acquisitions; product developments; partnerships, agreements, and collaborations; and expansions in the laboratory automation market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the in vitro lung model market and estimate the size of other dependent submarkets. Various secondary sources such as the American Lung Association, National Center for Biotechnology Information, National Centre for Advancing Translational Sciences, European Union Reference Laboratory for alternatives to animal testing (EURL-ECVAM), European Lung Foundation, Annual Reports, Presentations, Press Releases, Journals, Paid Databases, have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

The major players in the in vitro lung model market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

Target Audience:

• Biotechnology companies that are into tissue engineering and development of 3D in vitro models
• Pharmaceutical industries
• Academic and government research institutes
• Contract research organizations (CROs)
• Venture capitalists and investors

In Vitro Lung Model Market Scope

The research report categorizes the in vitro lung model market into the following segments and subsegments:

By Type

• 2D Models
• 3D Models
  • In-house 3D Models
  • Commercialized 3D Models

By Application

• Applications of 2D Models
  • Drug Discovery and Toxicology
  • 3D Model Development
  • Basic Research
• Applications of 3D Models
  • Drug Discovery and Toxicology
  • Physiological Research
  • Stem Cell Research and Regenerative Medicine

By Region

• North America
• Europe
• Asia Pacific
• Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (Up to 5)

The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models.

The report analyzes the lung in vitro models market by type, applications, and region. Based on type, the in vitro lung model market is segmented into 2D cell models and 3D cell models. 3D cell models is further segmented into in-house and commercialized 3D models (ready-to-use). The 3D cell models segment is projected to grow at the fastest rate during the forecast period due to the rising need for efficient lung in vitro models that mimic in vivo physiology.

Based on application, the market is segmented into applications of 2D models and 3D models. Applications of 2D models include drug discovery and toxicology, 3D model development, and basic research. The drug discovery and toxicology segment is expected to hold the largest share of 2D applications in 2018. The drug discovery and toxicology applications dominated the 2D application segment owing to the flexibility and high throughput capabilities of 2D cell models. Applications of 3D models include drug discovery and toxicology, physiological research, and stem cell research & regenerative medicine. The drug discovery and toxicology segment applications of 3D lung in vitro models are expected to dominate the market in 2018. The 3D cell models provide the relevant in vivo environment and reproducibility for drug discovery and toxicology applications.

Based on region, the in vitro lung model market is segmented into North America, Europe, Asia Pacific, and the RoW. In 2018, North America is projected to account for the largest share of the global lung in vitro models market. The development in the market in North America is driven by the flourishing research environment and abundant funding program such as increased funds for the National Institutes of Health (NIH) and increased R&D activities by biotechnology and pharmaceutical companies.

However, the dearth of skilled professionals such as researchers and technicians that are required to set up and run experiments involving complex in vitro models, is likely to be a challenge for market growth.

The major players in the lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst